The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Capecitabine Teva 500 mg film-coated tablets

Teva B.V.EU/1/12/761/002

Main Information

Trade NameCapecitabine Teva 500 mg film-coated tablets
Active SubstancesCapecitabine
Dosage FormFilm-coated tablet
Licence HolderTeva B.V.
Licence NumberEU/1/12/761/002

Group Information

ATC CodeL01BC Pyrimidine analogues
L01BC06 capecitabine


License statusAuthorised
Licence Issued20/04/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0079-117-003
Interchangeable List DocumentPDF of Interchangeable List
« Back